Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

12.90
Delayed Data
As of Dec 07
 -0.45 / -3.37%
Today’s Change
6.17
Today|||52-Week Range
14.69
+4.12%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close13.35
Today’s open13.20
Day’s range12.50 - 13.40
Volume76,211
Average volume (3 months)156,335
Market cap$464.5M
Dividend yield--
Data as of 12/07/2016

Growth & Valuation

Earnings growth (last year)+35.31%
Earnings growth (this year)-22.82%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.23

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp0.000.00%
NERVMinerva Neuroscience...-0.80-5.93%
CYTKCytokinetics Inc-0.10-0.88%
OMEROmeros Corp-0.63-5.67%
Data as of 12/07/2016

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$0.00
Annual profit (last year)-$82.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs